LEAVING OUR WEBSITE

You are now leaving our website.
Kindly note that this link is offered as a service and EVER is not responsible for any content published on the thirds-party website you are about to enter.

Cerebrolysin - General information
  • Home
  • Cerebrolysin®
    • About Cerebrolysin®
    • Safety
    • Mode of Action
    • Prescribing Information
    • Administration
    • FAQs
    • Download Area
  • Stroke
    • Disease
    • Clinical Efficacy
    • Administration
    • Expert Interviews
    • Rehabilitation
    • Trainings
    • Download Area
  • Dementia
    • Disease
    • Clinical Efficacy
    • Administration
    • Download Area
  • TBI
    • Disease
    • Clinical Efficacy
    • Administration
    • Expert Interviews
    • Download Area
  • News
  • Webinars
  • Links
  • Search
     
Dementia
  • Disease
  • Clinical Efficacy
  • Administration
  • Download Area
  1. Dementia
  2. Download Area

Download area - Dementia

Cerebrolysin® Dementia Broschures

Brochure about Effective treatment for Neurocognitive Disorders
Brochure about Effective treatment for Neurocognitive DisordersResults of Cerebrolysin® in patients with neurocognitive disorders in different affected domains
Brochure about the meta-analysis of Gauthier
Brochure about the meta-analysis of GauthierThis brochure shows the results of a meta-analysis in the field of Alzheimer's disease

Cerebrolysin® Study Posters - Dementia

Study poster Alvarez et al., 2010
Study poster Alvarez et al., 2010Neurotrophic and cholinergic treatment in Alzheimer's disease (Cerebrolysin® and Donepezil combination therapy)306 KB
Study poster Chen et al., 2013
Study poster Chen et al., 2013Cerebrolysin® for vascular dementia (Cochrane Review)66 KB
Study poster Ruether et al., 2001
Study poster Ruether et al., 2001Cerebrolysin® in patients with mild to moderate Alzheimer's disease172 KB
Study poster Gauthier et al., 2015
Study poster Gauthier et al., 2015Cerebrolysin® in mild to moderate Alzheimer's disease: A meta-analysis63 KB

> General Cerebrolysin® Information

Products
  • Imprint
  • Disclaimer
  • Data Privacy
  • Terms of Use
  • Sitemap
  • Adverse Events
  • Contact

© 2022 EVER Neuro Pharma GmbH

To access the site for information on Cerebrolysin® please confirm that you are a healthcare professional.

No, I am not a healthcare professional